financetom
Business
financetom
/
Business
/
Trump reverses Biden-era rules on copper smelters
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Trump reverses Biden-era rules on copper smelters
Oct 26, 2025 3:41 PM

WASHINGTON (Reuters) -U.S. President Donald Trump on Friday reversed a Biden-era air pollution rule that had imposed stricter limits on emissions from copper smelters.

The copper rule, finalized in May 2024, had required smelters to curb pollutants including lead, arsenic, mercury, benzene and dioxins under updated federal air standards.

Trump's proclamation grants a two-year exemption from compliance for affected stationary sources, which the White House said would help promote American mineral security by reducing regulatory burdens on domestic copper producers.

"Imposing these requirements on such a limited and already strained domestic industry risks accelerating further closures, weakening the Nation's industrial base, undermining mineral independence, and increasing reliance on foreign-controlled processing capacity," the White House said in announcing the changes.

The proclamation referenced the two copper smelters in the United States, one operated by Freeport-McMoRan in Arizona and the other by Rio Tinto in Utah. It stated the order would apply to Freeport's smelter.

Phoenix-based Freeport thanked Trump and said the two-year exemption shows copper's importance for national security.

"This action acknowledges the operational realities facing domestic copper smelting and provides needed time to assess and plan for appropriate regulatory reconsideration of the Copper Rule and future implementation," a Freeport spokesperson said.

Rio Tinto said its Utah smelter was not affected by the 2024 order due to the company's investment in equipment that captures emissions.

"Rio Tinto's Kennecott copper operation in Utah has a long-standing commitment to reducing its environmental footprint through innovation and investment," a Rio spokesperson said.

Trump signed an executive order earlier this year that identified copper as a critical material for defense, infrastructure and emerging technologies, including clean energy and electric vehicles.

It led to a Section 232 investigation to determine whether copper imports threaten U.S. national security, particularly due to dependence on a small number of foreign suppliers.

Following the review, the administration imposed a 50% tariff on certain imported copper and mandated that an increasing percentage of high-quality scrap copper produced in the U.S. be sold domestically.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Fuel cell maker Ballard Power Q3 revenue beats estimates on higher deliveries
Fuel cell maker Ballard Power Q3 revenue beats estimates on higher deliveries
Nov 13, 2025
Overview * Ballard Q3 2025 revenue up 120% YoY to $32.5 mln, beating analyst expectations * Gross margin improved to 15%, a 71-point increase YoY * Company reduced operating expenses by 36% due to restructuring Outlook * Company revises 2025 capital expenditure guidance to $8-$12 mln from $15-$25 mln * Ballard expects 2025 operating expenses to be below lower end...
Clinic operator NeuPath's Q3 revenue beats on fluoroscopy demand
Clinic operator NeuPath's Q3 revenue beats on fluoroscopy demand
Nov 13, 2025
Overview * NeuPath Q3 revenue rises 26% yr/yr, beating analyst expectations * Adjusted EBITDA for Q3 up 98% yr/yr, marking 27th consecutive positive quarter * Company attributes growth to optimized clinic footprint and increased patient treatment time Outlook * NeuPath expects continued organic and inorganic growth for the balance of 2025 and beyond * Company anticipates strong demand for Arthrosamid...
PDS Biotechnology Q3 net loss narrows on lower operating expenses
PDS Biotechnology Q3 net loss narrows on lower operating expenses
Nov 13, 2025
Overview * PDS Biotechnology ( PDSB ) Q3 net loss decreases to $9 mln due to lower operating expenses * Adjusted EPS for Q3 beats analyst expectations * Company plans expedited approval for VERSATILE-003 Phase 3 trial Outlook * PDS Biotech plans to seek accelerated approval for VERSATILE-003 Phase 3 trial * Company proposes amendment to use PFS as surrogate...
Sagimet Biosciences Q3 net loss narrows as costs drop
Sagimet Biosciences Q3 net loss narrows as costs drop
Nov 13, 2025
Overview * Sagimet reports Q3 net loss of $12.9 mln * R&D expenses for Q3 2025 decreased to $9.7 mln from $12.7 mln in Q3 2024 * Cash and equivalents stand at $125.5 mln as of September 30, 2025 Outlook * Sagimet anticipates Phase 1 trial data readout for denifanstat and resmetirom in 1H 2026 * Company plans Phase 2...
Copyright 2023-2026 - www.financetom.com All Rights Reserved